Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcie Riches

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Current Opinion in Hematology|August 30, 2021
The new world: hematopoietic stem cell transplant during a pandemicMarcie Riches
Transplantation and Cellular Therapy|October 5, 2020
Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation StudiesSoyoung Kim, Brent Logan, Marcie Riches, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 21, 2021
Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and costKevin Y Chen, Tyler G Bucci, J Ryan Shaw, et al.
Transplantation and Cellular Therapy|April 25, 2021
COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes ForumJohn R Wingard, Kwang Woo Ahn, Christopher Dandoy, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphomaErnesto Ayala, Javier Figueroa, Janelle Perkins, et al.
Haematologica|December 15, 2022
A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantationMichelle Hudspeth, Shahram Mori, David Nachbaur, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2020
Evaluation of mobilization efficacy with an extended interval following plerixafor administrationSarah E Stump, Morgan Trepte, J Ryan Shaw, et al.
British Journal of Haematology|October 2, 2014
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasiaJuliet N Barker, Mingwei Fei, Chatchada Karanes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2020
Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell TransplantationGeorge L Chen, Paul K Wallace, Yali Zhang, et al.
Bone Marrow Transplantation|April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host diseaseLia Perez, Hugo Fernandez, Pedro Horna, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Current Opinion in Hematology|August 30, 2021
The new world: hematopoietic stem cell transplant during a pandemicMarcie Riches
Transplantation and Cellular Therapy|October 5, 2020
Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation StudiesSoyoung Kim, Brent Logan, Marcie Riches, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 21, 2021
Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and costKevin Y Chen, Tyler G Bucci, J Ryan Shaw, et al.
Transplantation and Cellular Therapy|April 25, 2021
COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes ForumJohn R Wingard, Kwang Woo Ahn, Christopher Dandoy, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphomaErnesto Ayala, Javier Figueroa, Janelle Perkins, et al.
Haematologica|December 15, 2022
A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantationMichelle Hudspeth, Shahram Mori, David Nachbaur, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2020
Evaluation of mobilization efficacy with an extended interval following plerixafor administrationSarah E Stump, Morgan Trepte, J Ryan Shaw, et al.
British Journal of Haematology|October 2, 2014
Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasiaJuliet N Barker, Mingwei Fei, Chatchada Karanes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2020
Low-Level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen-Specific T Cells after Allogeneic Hematopoietic Cell TransplantationGeorge L Chen, Paul K Wallace, Yali Zhang, et al.
Bone Marrow Transplantation|April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host diseaseLia Perez, Hugo Fernandez, Pedro Horna, et al.
Pageof 5